Epidemiological, clinical and mortality trends in people living with HIV over 60 years in the PISCIS population-based cohort from Catalonia and Balearic Islands
Andreu Bruguera(Badalona Serveis Assistencials), Juliana Reyes‐Urueña(Generalitat de Catalunya), Juan Tiraboschi(Bellvitge University Hospital), Aroa Villoslada(Hospital Son Llatzer), Francisco Fanjul(Hospital Universitario Son Espases), Daniel K. Nomah(Universitat Autònoma de Barcelona), Ángeles Jaén, Jordi Navarro(Universitat Autònoma de Barcelona), Peré Domingo(Hospital de Sant Pau), Estebán Martínez(Instituto de Salud Carlos III), Jordi Casabona(Centro de Estudios Políticos y Constitucionales), José M Miró(Instituto de Salud Carlos III), Eugènia Negredo(Universitat de Vic - Universitat Central de Catalunya), Joaquim Peraire(Instituto de Salud Carlos III), Sergio Moreno‐Fornés(Generalitat de Catalunya)
Cited by 1
Related Papers
Pitavastatin to Prevent Cardiovascular Disease in HIV Infection
|New England Journal of Medicine|2023|476
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342
Dual treatment with lopinavir–ritonavir plus lamivudine versus triple treatment with lopinavir–ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial
|The Lancet Infectious Diseases|2015|143